SCHEMBL21941492

SCHEMBL21941492

CC(C)(C)c1cc(CC(C)(C)c2cccc3nonc23)c2nonc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.33
▸ MAPK1 P28482 3/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ CASP1 P29466 2/20 0.33
▸ CASP7 P55210 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ MET P08581 2/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ ALDH1A1 P00352 7/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ APP P05067 1/20 0.31
▸ POLB P06746 2/20 0.31
▸ GFER P55789 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21577670 0.82 KMT2A (0.35) KMT2AMAPK1MEN1L3MBTL1TDP1
SCHEMBL23874215 0.80 KMT2A (0.37) KMT2AMAPK1MEN1L3MBTL1TDP1
SCHEMBL21577671 0.74 MAPT (0.36) KMT2AMEN1HSD17B10ALDH1A1KDM4E
SCHEMBL19040901 0.74 KMT2A (0.41) KMT2AMAPK1MEN1L3MBTL1TDP1
SCHEMBL1104678 0.74 KMT2A (0.46) KMT2AMAPK1MEN1L3MBTL1TDP1
SCHEMBL22023973 0.72 KMT2A (0.40) KMT2AMAPK1MEN1L3MBTL1TDP1
SCHEMBL22332293 0.70 KMT2A (0.42) KMT2AMAPK1MEN1L3MBTL1TDP1
SCHEMBL6002955 0.68 KMT2A (0.44) KMT2AMAPK1MEN1L3MBTL1TDP1
SCHEMBL23597829 0.64 ALDH1A1 (0.39) KMT2AMAPK1MEN1L3MBTL1TDP1
SCHEMBL762080 0.64 TP53 (0.47) KMT2AMAPK1MEN1L3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200113913-A1 METHODS FOR HAIR FOLLICLE STEM CELL PROLIFERATION Frequency Therapeutics, Inc. 2020-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200113913-A1 METHODS FOR HAIR FOLLICLE STEM CELL PROLIFERATION SHH, WNT3A, WNT1 KMT2A 1917/4885MAPK1 1383/4885MEN1 4799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback